Human Papillomavirus Vaccine (HPV) 2019-2020 (2020-2021)

Hankinnan yleistiedot

03 - Ilmoitus tehdystä sopimuksesta (3)
Avoin menettely
24.4.2019 10.21 (GMT+03:00)

Hankintayksikkö

National Institute for Health and Welfare National Institute for Health and Welfare
PL 30
00271 Helsinki
Suomi
2229500-6

Hankintapäätös

The Ministry of Social Affairs and Health (hereinafter ”STM”) and National Institute for Health and Welfare (hereinafter “THL” or “Customer”) request your tender for Human Papillomavirus Vaccine (HPV) belonging to the National Vaccination Programme in Finland. The contract period is 1 year (during 2019-2020). The extend of the contract (option period) is 1 year (during 2020-2021). Estimated quantity for the contract period including option is 94 000 doses. The customer reserves the right to increase or decrease the ordered numbers of doses by up to 20 %. The customer will choose the supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The tenderer that quoted the lowest reference price per dose will be awarded the contract. Please note that all times given in the Invitation to tender are local time in Finland. Tender annexes: Annex 1 Contract Annex 2 JYSE 2014 SUPPLIES (link).

Mercell Suomi Oy

Osa Mercell-ryhmää, Euroopan johtavaa hankintapalvelujen sekä sähköisen kilpailutusjärjestelman tuottajaa.

Yleistä hankinnoista

Hankintalaki
TED

Yhteydenotto

Klikkaa tästä asiakaspalveluun

+358 207 528 600